Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 13Gastrointestinal 9Other hematologic neoplasm 7Genitourinary 7Thoracic 6Plasma cell 6Other 6Gynecologic 6Sarcoma 4Myeloid 4Lymphoid 4Head & Neck 4Tumor-Agnostic 3CNS 3Classical hematology 2Other solid neoplasm 1Other neoplasm 1NET 1Endocrine 1Dermatologic 1

Conditions

Neoplasms 3

Interventions

Paclitaxel 26Carboplatin 25pembrolizumab 22Gemcitabine 22Nivolumab 20Cisplatin 15Bevacizumab 14Docetaxel 13Pemetrexed 12Ipilimumab 12Erlotinib Hydrochloride 12Capecitabine 12Fluorouracil 11Irinotecan 10Afatinib 10eribulin 9BI 6727 9130-nm albumin-bound paclitaxel 9Radiotherapy 8Magnetic Resonance Spectroscopy 8Leucovorin 8Everolimus 8Cyclophosphamide 8Albumin-Bound Paclitaxel 8olaparib 7Oxaliplatin 7lenvatinib 6avelumab 6Trastuzumab 6Cetuximab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Surveys and Questionnaires × Tumor-Agnostic × Clear all
NCT03839940 2025-01-29

MIST

Alliance for Clinical Trials in Oncology

Phase 3 Terminated
39 enrolled 18 charts
Tumor-Agnostic

Neoplasms

NCT05070897 2024-06-12

LICAPA

Institut Bergonié

Completed
1,518 enrolled 11 charts
Tumor-Agnostic

Neoplasms

NCT02274493 2019-03-26

Robotic Harvest of the Latissimus Dorsi (LD) Muscles

M.D. Anderson Cancer Center

Phase NA Completed
15 enrolled 11 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡